Company Profiles

driven by the PitchBook Platform

CMDBioscience

Description

Developer of peptide drug designed to drive innovative peptide drug discovery and build value through strategic partnering arrangements with leading companies and academic institutions. The company's peptide drugs are made, using computational methods that enables users to have multi-function peptide drugs for leukemia and lymphoma.

2006

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$250k

Latest Deal Amount

$6.98M

Total Amount Raised

Description

Developer of peptide drug designed to drive innovative peptide drug discovery and build value through strategic partnering arrangements with leading companies and academic institutions. The company's peptide drugs are made, using computational methods that enables users to have multi-function peptide drugs for leukemia and lymphoma.

Website:

www.cmdbioscience.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Social/Platform Software

Primary Office

554 Boston Post Road Suite 318 Orange, CT 06477United States +1 (203) 298-4251
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore CMDBioscience's full profile, request a free trial.

    CMDBioscience Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    CMDBioscience Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    CMDBioscience Investors (4)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Connecticut InnovationsVenture CapitalMinority000 0000000 0000
    Enhanced Capital PartnersAsset ManagerMinority000 0000000 0000
    LaunchCapitalVenture CapitalMinority000 0000000 0000
    Mohegan TribeOtherMinority000 0000000 0000
    Connecticut Innovations Venture Capital
    Enhanced Capital Partners Asset Manager
    LaunchCapital Venture Capital
    Mohegan Tribe Other

    CMDBioscience Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Joseph Audie Ph.DChief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member
    Charles Boyd Ph.DChief Investigational Scientist
    David Diller Ph.DSenior Director of Computational Chemistry
    Mark Jarosinski Ph.DSenior Director, Peptide Medicinal Chemistry & Business Development
    Joseph Audie Ph.D Chief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member
    Charles Boyd Ph.D Chief Investigational Scientist
    David Diller Ph.D Senior Director of Computational Chemistry
    Mark Jarosinski Ph.D Senior Director, Peptide Medicinal Chemistry & Business Development

    CMDBioscience Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Daniel WagnerConnecticut InnovationsManaging Director, Investments000 0000
    Gerald VovisCMDBioscienceBoard Member000 0000
    Joseph Audie Ph.DCMDBioscienceChief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member000 0000
    Konstantine DrakonakisLaunchCapitalVenture Partner000 0000
    Daniel Wagner Managing Director, Investments Connecticut Innovations
    Gerald Vovis Board Member CMDBioscience
    Joseph Audie Ph.D Chief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member CMDBioscience
    Konstantine Drakonakis Venture Partner LaunchCapital
    Request full access to PitchBook